Головная боль, эпилептические припадки, когнитивные расстройства и цереброваскулярные заболевания как самые распространенные нейропсихические синдромы при системной красной волчанке
https://doi.org/10.14412/1995-4484-2014-222-227
Аннотация
Нервная система часто вовлекается в патологический процесс при системной красной волчанке (СКВ). Нейропсихическая СКВ включает комплекс синдромов. Самыми распространенными являются головная боль, эпилептические припадки, когнитивные расстройства, цереброваскулярные заболевания. Патогенети- ческие механизмы развития нейропсихических синдромов различны. Диагностические и терапевтические стратегии должны быть индивидуализированы для заболевания и пациента. В данной статье будут представ- лены литературные и наши данные по основным наиболее часто встречающимся нейропсихическим син- дромам, развивающимся на фоне СКВ.
Об авторе
Н. В. Пизова
ГБОУ ВПО «Ярославская государственная медицинская академия» Минздрава России, Ярославль, Россия
Россия
Россия
Список литературы
1. Иванова ММ. Системная красная волчанка. Клиника, диагностика и лечение. Клиническая ревматология. 1995;(1):2–19. [Ivanova MM. Systemic lupus erythematosus. Clinic, diagnostics and treatment. Klinicheskaya revmatologiya. 1995;(1):2–19. (In Russ.)]
2. Иванова ММ. ЦНС-люпус: проблемы и достижения (результаты 10-летнего клинико-инструментального исследования) (лекция). Терапевтический архив. 2001;73(5):25–9. [Ivanova MM. TsNS-lyupus: problems and achievements (results of 10 years' kliniko-tool research) (lecture). Terapevticheskii arkhiv. 2001;73(5):25–9. (In Russ.)]
3. Насонова ВА, Бунчук НВ, редакторы. Ревматологические болезни. Руководство для врачей. Москва: Медицина; 1997. 520 с. [Nasonova VA, Bunchuk NV, editors. Revmatologicheskie bolezni. Rukovodstvo dlya vrachei. [Rheumatologic diseases. The management for doctors]. Moscow: Meditsina; 1997. 520 p.]
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythemato- sus. Arthritis Rheum. 1997;40(9):1725. DOI: http://dx.doi.org/10.1002/art.1780400928.
5. Kassan SS, Lockshin MD. Central nervous system lupus erythe- matosus. The need for classification. Arthritis Rheum. 1979;22(12):1382–5. DOI: http://dx.doi.org/10.1002/art.1780221210.
6. Пизова НВ. Неврологические и психические расстройства при системной красной волчанке. Журнал неврологии
7. и психиатрии им. С.С. Корсакова. 2010;110(8):76–83. [Pizova NV. Neuropsychiatric disorders in systemic lupus erythematosus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2010;110(8):76–83. (In Russ.)]
8. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a com- parison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore). 2003;82(5):299–308. DOI: http://dx.doi.org/10.1097/01.md.0000091181.93122.55.
9. Ainiala H, Hietaharju A, Loukkola J, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45(5):419–23. DOI: http://dx.doi.org/10.1002/1529- 0131(200110)45:5<419::AID-ART360>3.0.CO;2-X.
10. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syn- dromes in lupus. Prevalence using standardized definitions. Neurology. 2002;58(8):1214–20. DOI:
11. http://dx.doi.org/10.1212/WNL.58.8.1214.
12. Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol. 2005;19(5):799–821. DOI:
13. http://dx.doi.org/10.1016/j.berh.2005.04.003.
14. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 1971;50(2):85–95. DOI: http://dx.doi.org/10.1097/00005792- 197103000-00001.
15. Feng PH, Cheah PS, Lee YK. Mortality in systemic lupus erythe- matosus. A 10-year review. Br Med J. 1973;4(5896):772–4. DOI: http://dx.doi.org/10.1136/bmj.4.5895.772.
16. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25(6):606–11. DOI: http://dx.doi.org/10.1002/art.1780250601.
17. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus. II. Causes of death. Arthritis Rheum. 1982;25(6):612–7. DOI: http://dx.doi.org/10.1002/art.1780250602.
18. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608. DOI: http://dx.doi.org/10.1002/1529- 0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F.
19. Файзулина ДЛ, Шпрах ВВ. Поражение нервной системы при системной красной волчанке. Сибирский медицинский журнал (Иркутск). 2009;90(7):5–10. [Faizulina DL, Shprah VV. The damage of nervous system in lupus erythematosus. Sibirskii meditsinskii zhurnal (Irkutsk). 2009;90(7):5–10. (In Russ.)]
20. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Systemic lupus international collaborating clinics. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an inter- national inception cohort study. Arthritis Rheum. 2007;56(1):265–73. DOI: http://dx.doi.org/10.1002/art.22305.
21. Petri M, Naqibuddin M, Carson KA, et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol. 2008;35(9):1776–81. Epub 2008 Jul 15.
22. Unterman A, Nolte JE, Boaz M, et al. Neuropsychiatric syn- dromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1–11. DOI: 10.1016/j.semarthrit.2010.08.001. Epub 2010 Oct 20.
23. Robert M, Sunitha R, Thulaseedharan NK. Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurol India. 2006;54(1):75–7. DOI: http://dx.doi.org/10.4103/0028-3886.24713.
24. Appenzeller S, Costallat L. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ dam- age. Cephalalgia. 2004;24(12):1024–30. DOI: http://dx.doi.org/10.1111/j.1468-2982.2004.00785.x.
25. Glanz BI, Venkatesan A, Schur PH, et al. Prevalence of migraine in patients with systemic lupus erythematosus. Headache. 2001;41(3):285–9. DOI: http://dx.doi.org/10.1046/j.1526- 4610.2001.111006285.x.
26. Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004;127(5):1200–9. DOI: http://dx.doi.org/10.1093/brain/awh146.
27. Lessa B, Santana A, Lima I, et al. Prevalence and classification of headache in patients with systemic lupus erythematosus. Clin Rheumatol. 2006;25(6):850–3. Epub 2006 Jan 26. DOI: http://dx.doi.org/10.1007/s10067-005-0186-x.
28. Fernandez-Nebro A, Palacios-Munoz R, Gordillo J, et al. Chronic or recurrent headache in patients with systemic lupus ery- thematosus: a case control study. Lupus. 1999;8(2):151–6. DOI: http://dx.doi.org/10.1191/096120399678847443.
29. Goh R, Heritzen A, Tan CT, Hoh MC. Headaches and systemic lupus erythematosus: is there an entity of «lupus headache»? Neurol J Southeast Asia. 1997;(2):51–6.
30. Sfikakis PP, Mitsikostas DD, Manoussakis MN, et al. Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol. 1998;37:300–3. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/37.3.300.
31. Amit M, Molad Y, Levy O, Wysenbeek AJ. Headache in systemic lupus erythematosus and its relation to other disease manifesta- tions. Clin Exp Rheumatol. 1999;17(4):467–70.
32. Isenberg DA, Meyrick-Thomas D, Snaith ML, et al. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis. 1982;41(1):30–2. DOI: http://dx.doi.org/10.1136/ard.41.1.30.
33. Appenzeller O. Return to the headache in systemic lupus erythe- matosus using modern technology. Cephalalgia. 1998;18(4):171–2. DOI: http://dx.doi.org/10.1046/j.1468-2982.1998.1804171-3.x.
34. Laversuch CJ, Brown MM, Clifton A, Bourke BE. Cerebral venous thrombosis and acquired protein S deficiency:
35. an uncommon cause of headache in systemic lupus erythematosus. Br J Rheumatol. 1995;34(6):572–5. DOI: http://dx.doi.org/10.1093/rheumatology/34.6.572.
36. Vidailhet M, Piette JC, Wechsler B, et al. Cerebral venous throm- bosis in systemic lupus erythematosus. Stroke. 1990;21(8):1226–31. DOI: http://dx.doi.org/10.1161/01.STR.21.8.1226.
37. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989;20(5):583–91. DOI: http://dx.doi.org/10.1161/01.STR.20.5.583.
38. Nakai Y, Hyodo A, Yanaka K, et al. Distal superior cerebellar artery aneurysm in a patient with systemic lupus erythematosus: case report. Surg Neurol. 2000l;54(1):73–6. DOI: http://dx.doi.org/10.1016/S0090-3019(00)00261-5.
39. Пизова НВ. Системная красная волчанка и эпилепсия. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;(3 приложение 2):35–8. [Pizova NV. Sistemnaya krasnaya volchanka i epilepsiya. Zhurnal nevrologii i psikhiatrii im.
40. S.S. Korsakova. 2010;(3 Suppl 2):35–8. (In Russ.)]
41. Mayes B, Brey R. Evaluation and treatment of seizures in patients
42. with systemic lupus erythematosus. J Clin Rheumatol. 1996;2(6):336–45. DOI: http://dx.doi.org/10.1097/00124743- 199612000-00007.
43. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature inves- tigation. Rheumatology (Oxford). 2002;41(6):605–18. DOI: http://dx.doi.org/10.1093/rheumatology/41.6.605.
44. Herranz MT, Rivier G, Khamashta MA, et al. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 1994;37(4):568–71. DOI: http://dx.doi.org/10.1002/art.1780370418.
45. Mackworth-Young CG, Hughes GR. Epilepsy: an early symptom of SLE. J Neurol Neurosurg Psychiatry. 1985;48(2):185. DOI: http://dx.doi.org/10.1136/jnnp.48.2.185.
46. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001;28(4):766–71.
47. Kampylafka EI, Alexopoulos H, Kosmidis ML, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One. 2013;8(2):e55843. DOI: 10.1371/journal.pone.0055843. Epub 2013 Feb 12.
48. Aarli J. Epilepsy and the immune system. Arch Neurol. 2000;57(12):1689–92. DOI: http://dx.doi.org/10.1001/arch- neur.57.12.1689.
49. Liou HH, Wang CR, Chen CJ, et al. Elevated levels of anticardi- olipin antibodies and epilepsy in lupus patients. Lupus. 1996;5(4):307–12. DOI: http://dx.doi.org/10.1177/096120339600500412.
50. Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neu- ropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58(4):1130–5. DOI: 10.1002/art.23399.
51. Kozora E, West SG, Maier SF, et al. Antibodies against N-methyl- D-aspartate receptors in patients with systemic lupus erythemato- sus without major neuropsychiatric syndromes. J Neurol Sci. 2010;295(1–2):87–91. DOI: 10.1016/j.jns.2010.04.016. Epub 2010 May 23.
52. Postal M, Costallat LTL, Appenzeller S. Neuropsychiatric mani- festations in systemic lupus erythematosus: Epidemiology, patho- physiology and management. CNS Drugs. 2011;25(9):721–36. DOI: 10.2165/11591670-000000000-00000.
53. Yoshio T, Hirata D, Onda K, et al. Antiribosomal P protein anti- bodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2005;32(1):34–9.
54. Andrade RM, Alarcon GS, Gonzalez LA, et al.; LUMINA Study Group. Seizures in patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis. 2008;67(6):829–834. Epub 2007 Sep 17. DOI: http://dx.doi.org/10.1136/ard.2007.077594.
55. Malik S, Bruner GR, Williams-Weese C, et al. Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients. Lupus. 2007;16(11):863–6. DOI: http://dx.doi.org/10.1177/0961203307083365.
56. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis. 1986;174(6):357–64. DOI: http://dx.doi.org/10.1097/00005053- 198606000-00008.
57. Carlomagno S, Migliaresi S, Ambrosone L, et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol. 2000;247(4):273–9. DOI: http://dx.doi.org/10.1007/s004150050583.
58. Glanz BI, Slonim D, Urowitz MB, et al. Pattern of neuropsycho- logical dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10:232–8.
59. Hanly JG, Fisk JD, Sherwood G, et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol. 1992;19(4):562–7.
60. Hay EM, Black D, Huddy A, et al. Psychiatric disorder and cog- nitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992;35(4):411–6. DOI: http://dx.doi.org/10.1002/art.1780350409.
61. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cogni- tive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1996;39(12):2035–45. DOI:http://dx.doi.org/10.1002/art.1780391213.
62. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern
63. Chinese patients with systemic lupus erythematosus. Medicine (Baltimore). 2006;85(4):221–8. DOI: http://dx.doi.org/10.1097/01.md.0000231955.08350.1b.
64. McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythemato- sus. Neurology. 2005;64(2):297–303. DOI: http://dx.doi.org/10.1212/01.WNL.0000149640.78684.EA.
65. Gladman DD, Urowitz MB, Slonim D, et al. Evaluation of pre- dictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol. 2000;27(10):2367–71.
66. Carbotte RM, Denburg SD, Denburg JA. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol. 1995;22(5):863–7.
67. Rogers MP, Waterhouse E, Nagel JS, et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cogni- tive and other minor neuropsychiatric symptoms: a pilot study. Lupus. 1992;1(4):215–9. DOI: http://dx.doi.org/10.1177/096120339200100404.
68. Tomietto P, Annese V, D'Agostini S, et al. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo. 2003;55(3):171–80.
69. Waterloo K, Omdal R, SjЪholm H, et al. Neuropsychological dys- function in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol. 2001;248(7):595–602. DOI: http://dx.doi.org/10.1007/s004150170138.
70. Shucard JL, Gaines JJ, Ambrus J Jr, Shucard DW. C-reactive pro- tein and cognitive deficits in systemic lupus erythematosus. Cogn Behav Neurol. 2007;20(1):31–7. DOI: http://dx.doi.org/10.1097/WNN.0b013e31802e3b9a.
71. Asherson RA, Mercey D, Phillips G, et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: associa- tion with antiphospholipid antibodies. Ann Rheum Dis. 1987;46(8):605–11. DOI: http://dx.doi.org/10.1136/ard.46.8.605.
72. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum. 1999;42(4):728–34. DOI: http://dx.doi.org/10.1002/1529-0131(199904)42:4<728::AID- ANR16>3.0.CO;2-O.
73. Long AA, Denburg SD, Carbotte RM, et al. Serum lymphocyto- toxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis. 1990;49(4):249–53. DOI: http://dx.doi.org/10.1136/ard.49.4.249.
74. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and anti-neuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum. 1998;41(10):1819–27. DOI: http://dx.doi.org/10.1002/1529-0131(199810)41:10<1819::AID- ART14>3.0.CO;2-Y.
75. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, et al. The clini- cal relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis. 2000;59(2):99–104. DOI: http://dx.doi.org/10.1136/ard.59.2.99.
76. Kitagawa Y, Gotoh F, Koto A, Okayasu H. Stroke in systemic lupus erythematosus. Stroke. 1990;21(11):1533–9. DOI: http://dx.doi.org/10.1161/01.STR.21.11.1533.
77. Krishnan E. Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med. 2005;118(12):1415. DOI: http://dx.doi.org/10.1016/j.amjmed.2005.05.026.
78. Ward MM. Premature morbidity from cardiovascular and cere- brovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42:338–46. DOI: http://dx.doi.org/10.1002/1529-0131(199902)42:2<338::AID-
79. ANR17>3.0.CO;2-U.
80. Bessant R, Duncan R, Ambler G, et al. Prevalence of convention-
81. al and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum. 2006;55(6):892–9. DOI: http://dx.doi.org/10.1002/art.22343.
82. Mitsias P, Levine SR. Large vessel occlusive disease in systemic lupus erythematosus. Neurology. 1994;44(3 Pt 1):385–93. DOI: http://dx.doi.org/10.1212/WNL.44.3_Part_1.385.
83. Zö ller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41. DOI: 10.1186/1471-2377-12- 41.
84. Booth S, Chohan S, Curran JC, et al. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythe- matosus. Arthritis Rheum. 2007;57(5):845–50. DOI: http://dx.doi.org/10.1002/art.22766.
85. Gonzales-Portillo F, McIntyre JA, Wagenknecht DR, et al. Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease. J Stroke Cerebrovasc Dis. 2001;10(5):222–6. DOI: http://dx.doi.org/10.1053/jscd.2001.29818.
86. Blohorn A, Guegan-Massardier E, Triquenot A, et al. Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovasc Dis. 2002;13(3):156–62. DOI: http://dx.doi.org/10.1159/000047769.
87. Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology. 2002;41(6):619–30. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/41.6.619.
88. Calvo-Alen J, Alarcon GS, Tew MB, et al.; LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannosebinding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum. 2006;54(6):1940–5. DOI: http://dx.doi.org/10.1002/art.21787.
89. Goel D, Reddy SR, Sundaram C, et al. Active necrotizing cerebral vasculitis in systemic lupus erythematosus. Neuropathology. 2007;27(6):561–5. DOI: http://dx.doi.org/10.1111/j.1440- 1789.2007.00813.x.
90. Conen KL, Jeanneret C, Hecker B, et al. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: arteritis or atherosclerosis? Arthritis Rheum. 2006;54(3):908–13. DOI: http://dx.doi.org/10.1002/art.21656.
91. Mikdashi J, Handwerger B, Langenberg P, et al. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemicstroke and stroke severity in systemic lupus erythemato- sus. Stroke. 2007;38(2):281–5. DOI: http://dx.doi.org/10.1161/01.STR.0000254476.05620.14. Epub 2007 Jan 11.
92. Gao N, Wang ZL, Li MT, et al. Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythemato- sus. Lupus. 2013;22(5):453–60. DOI: 10.1177/0961203313477226.
93. Donders RC, Kappelle LJ, Derksen RH, et al. Transient monocu- lar blindness and antiphospholipid antibodies in systemic lupus erythematosus. Neurology. 1998;51(2):535–40. DOI: http://dx.doi.org/10.1212/WNL.51.2.535.
94. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid syndrome in systemic lupus erythematosus. Medicine. 1989;68(6):353–65.
Рецензия
Для цитирования:
Пизова Н.В. Головная боль, эпилептические припадки, когнитивные расстройства и цереброваскулярные заболевания как самые распространенные нейропсихические синдромы при системной красной волчанке. Научно-практическая ревматология. 2014;52(2):222-227. https://doi.org/10.14412/1995-4484-2014-222-227
For citation:
Pizova N.V. HEADACHE, SEIZURES, COGNITIVE DISORDERS, AND CEREBROVASCULAR DISEASES AS THE MOST COMMON NEUROPSYCHIC SYNDROMES IN SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatology Science and Practice. 2014;52(2):222-227. (In Russ.) https://doi.org/10.14412/1995-4484-2014-222-227
Просмотров:
1227
Послать статью по эл. почте 